RFP
ABUS icon

Root Financial Partners’s Arbutus Biopharma ABUS Stock Holding History

Root Financial Partners’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26K Buy
+281
New +$1.23K ﹤0.01% 2508

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Root Financial Partners's ABUS Position: Q1 2026 in Review

Root Financial Partners opened a new position in Arbutus Biopharma (ABUS) in Q1 2026: 281 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #2508 among its holdings.

167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • Root Financial Partners held 281 shares of Arbutus Biopharma worth $1.26K as of Q1 2026.
  • Arbutus Biopharma was a new Root Financial Partners position in Q1 2026.
  • Arbutus Biopharma made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2508 holding.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.